SCHEMBL16570464

SCHEMBL16570464

CC1CN(c2ccc(Nc3cc4c(ccn4Cc4nccnc4N(C)S(C)(=O)=O)cn3)cc2)CCN1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FGFR4 P22455 2/20 0.38
▸ ROCK2 O75116 2/20 0.37
▸ ADRA2A P08913 1/20 0.37
▸ ADRA2B P18089 1/20 0.37
▸ ADRA2C P18825 1/20 0.37
▸ SRPK2 P78362 1/20 0.36
▸ SRPK1 Q96SB4 1/20 0.36
▸ WEE1 P30291 2/20 0.35
▸ CDK4 P11802 5/20 0.35
▸ JAK2 O60674 5/20 0.35
▸ JAK3 P52333 3/20 0.35
▸ CCND1 P24385 2/20 0.35
▸ CDK2 P24941 2/20 0.35
▸ PTK2 Q05397 2/20 0.35
▸ BRD4 O60885 3/20 0.34
▸ FYN P06241 2/20 0.34
▸ CDK6 Q00534 2/20 0.34
▸ FGFR1 P11362 1/20 0.34
▸ FGFR2 P21802 1/20 0.34
▸ FGFR3 P22607 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16570461 1.00 FGFR4 (0.38) FGFR4ROCK2ADRA2AADRA2BADRA2C
SCHEMBL16570558 0.90 STAT6 (0.42) FGFR4SRPK2SRPK1WEE1CDK4
SCHEMBL16570447 0.90 SRPK1 (0.48) ADRA2AADRA2BADRA2CSRPK2SRPK1
SCHEMBL17958785 0.90 SRPK1 (0.48) ADRA2AADRA2BADRA2CSRPK2SRPK1
SCHEMBL16570729 0.88 ROCK2 (0.37) ROCK2ADRA2AADRA2BADRA2CWEE1
SCHEMBL16570731 0.88 ROCK2 (0.37) ROCK2ADRA2AADRA2BADRA2CWEE1
SCHEMBL16570262 0.86 STAT6 (0.47) FGFR4WEE1JAK2JAK3PTK2
SCHEMBL16581016 0.86 STAT6 (0.47) FGFR4WEE1JAK2JAK3PTK2
SCHEMBL16580769 0.86 STAT6 (0.47) FGFR4WEE1JAK2JAK3PTK2
SCHEMBL16580779 0.80 SRPK1 (0.51) FGFR4SRPK2SRPK1JAK2JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160222014-A1 COMPOUNDS FOR REGULATING FAK AND/OR SRC PATHWAYS ASANA BIOSCIENCES, LLC (US) 2016-08-04 — — US claimed
WO-2015038417-A1 COMPOUNDS FOR REGULATING FAK AND/OR SRC PATHWAYS ASANA BIOSCIENCES, LLC (US) 2015-03-19 — — WO claimed
US-20160222014-A1 COMPOUNDS FOR REGULATING FAK AND/OR SRC PATHWAYS ASANA BIOSCIENCES, LLC (US) 2016-08-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160222014-A1 COMPOUNDS FOR REGULATING FAK AND/OR SRC PATHWAYS SRC, PTK2, FYN FGFR4 385/4885ROCK2 216/4885ADRA2A 3261/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback